CLINICAL_TRIALS
trial_result
· 2019-03-12
Clinical Trial Update: Enzalutamide in Patients With High-risk Prostate Cancer [Phase 2]
Summary
Phase 2 trial of enzalutamide in high-risk prostate cancer completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Case Comprehensive Cancer Center | Conditions: Adenocarcinoma of the Prostate | Phase 2 | Status: COMPLETED | Results posted: 2019-03-12